Latest Financial Management News

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

Gullewa Limited reports a robust cash balance of $9.087 million at the end of December 2024, supported by strong financing inflows despite ongoing exploration expenditures. The company’s quarterly cash flow highlights its strategic financial management as it advances key tenements in Western Australia.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

AVADA Group Limited reports a positive cash flow for Q4 2024, supported by increased collections and operational consolidation, even as government funding shifts delay project starts.

Holista Colltech Limited reports a notable financial recovery in 4QFY24, underpinned by strong cash inflows and a rebound in its Food Ingredients division, alongside a leadership change aimed at steering future growth.

Meeka Metals Limited reports a strong cash position of $55.259 million as of December 31, 2024, underpinning its exploration activities with nearly 30 quarters of funding available. Despite ongoing cash outflows from exploration and corporate costs, the company’s financial footing remains robust.

Pilbara Minerals reported a 14% drop in spodumene concentrate production for December Quarter FY25 amid operational shifts, yet revenue rose 3% driven by higher prices. The company advances its P1000 Project and secures approval to acquire Latin Resources, signaling growth ambitions.

Zoom2u Technologies reported a 5% increase in Q2 FY25 revenue to $1.66 million, alongside a modest EBITDA loss of $29,000. The company also adopted a new Treasury Management Policy to accept Bitcoin payments, signaling strategic innovation.

OM Holdings delivered a robust production update for Q4 2024, with ferrosilicon output rising sharply despite manganese ore price declines and operational challenges. The company also secured a top sustainability award and made significant debt repayments.

Parabellum Resources reports a capital return from its Temarise investment and a strategic board reshuffle, while progressing exploration plans across its New South Wales projects.

Entertainment Rewards Ltd has secured a pivotal amendment to its $22.5 million convertible loan, slashing interest costs and extending repayment terms to bolster its financial flexibility.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.